发明名称 CRYSTAL FORMS OF ASTAXANTHIN
摘要 The invention describes previously undisclosed crystal forms of astaxanthin designated crystal form I and II. It has been surprisingly found that the two crystal forms of astaxanthin show an improved bioavailability, a relatively high solubility in specific organic solvents and an increased long-term stability. For example the new forms are stable in solid form for at least 90 days at a temperature of 20° C.-40° C. It was further found that the two crystal forms can be prepared from each other. Therefore the invention also relates to methods for preparing said crystal forms. In addition, the invention relates to administration forms (hereinafter also called “formulations”) comprising one of the two crystal forms according to the invention or mixtures thereof dissolved or suspended in oil or organic-solvent.
申请公布号 US2014221694(A1) 申请公布日期 2014.08.07
申请号 US201414245930 申请日期 2014.04.04
申请人 DSM IP ASSETS B.V. 发明人 GUO Jingfei;JONES Matthew J.;SCHAEFER Christian;ULRICH Joachim;VERLHAC-TRICHET Viviane
分类号 A23K1/16;A23K1/18 主分类号 A23K1/16
代理机构 代理人
主权项 1. A method of preparing an administration form of astaxanthin with improved stability and bioavailability properties, the method comprising incorporating into the administration form at least one crystal form of astaxanthin designated crystal form I and II, wherein crystal form I is characterized by i) An XRPD (X-Ray Powder Diffraction) pattern comprising a peak between 20° and 21°, and ii) A DSC (Differential Scanning calorimeter) scan showing a phase transition at 225° C.-235° C.; and wherein crystal form II is characterized by i) an XRPD pattern comprising a peak at approximately 11° and 18°, and ii) a DSC scan showing a phase transition at 200° C.-220° C.
地址 Heerlen NL